e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diagnosis and management of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled NO levels – A new tool in decision-making about antibiotic treatment
N. Voskresenska, J. Voicehovska, G. Orlikov (Riga, Latvia)
Source:
Annual Congress 2013 –Diagnosis and management of respiratory diseases
Session:
Diagnosis and management of respiratory diseases
Session type:
Thematic Poster Session
Number:
4160
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Voskresenska, J. Voicehovska, G. Orlikov (Riga, Latvia). Exhaled NO levels – A new tool in decision-making about antibiotic treatment. Eur Respir J 2013; 42: Suppl. 57, 4160
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Exhaled nitric oxide and the therapeutic regimens in childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Comparison of exhaled nitric oxide values measured by two offline methods or NO breath
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Exhaled nitric oxide reference values in healthy Tunisian adults
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Exhaled nitric oxide measurement in the diagnosis and management of pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO)
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021
The effect of chlorine exposure on Exhaled Nitric Oxide in asthmatic children attending indoor swimming pool
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Exhaled nitric oxide in the assessment of asthma control
Source: Eur Respir J 2007; 30: Suppl. 51, 18s
Year: 2007
Inter-instrument variability in exhaled nitric oxide measurement and implications on test interpretation
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Exhaled nitric oxide as a biomarker in different COPD phenotypes
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS)
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Exhaled NO (FENO50) in COPD - Results from the TIE-study
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept